Labcorp Finalizes Acquisition of Select Assets of Invitae PR Newswire BURLINGTON, N.C., Aug. 5, 2024 Extends Labcorp's leadership in genetic testing solutions for oncology and select rare...
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx PR Newswire BURLINGTON, N.C., Aug. 2, 2024 PGDx elio™ plasma focus Dx is the industry's first and only kitted...
Labcorp Announces 2024 Second Quarter Results PR Newswire BURLINGTON, N.C., Aug. 1, 2024 Updates Full-Year Guidance Results from Continuing Operations for second quarter 2024 versus last...
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities PR Newswire BURLINGTON, N.C., and FREMONT, Calif., July 29...
Labcorp Declares Quarterly Dividend PR Newswire BURLINGTON, N.C., July 25, 2024 BURLINGTON, N.C., July 25, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive...
Labcorp to Announce Second Quarter Financial Results on August 1, 2024 PR Newswire BURLINGTON, N.C., July 1, 2024 BURLINGTON, N.C., July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global...
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials PR Newswire BURLINGTON, N.C., June 17, 2024 Suite of digital and data solutions designed to improve clinical trial efficiency...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.